BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7914908)

  • 1. Identification of a novel dimeric phosphoprotein (PP29/30) associated with signaling receptors in human T lymphocytes and natural killer cells.
    Schraven B; Ratnofsky S; Gaumont Y; Lindegger H; Kirchgessner H; Bruyns E; Moebius U; Meuer SC
    J Exp Med; 1994 Sep; 180(3):897-906. PubMed ID: 7914908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.
    Burgess KE; Yamamoto M; Prasad KV; Rudd CE
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9311-5. PubMed ID: 1384049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four CD45/P56lck-associated phosphorproteins (pp29-pp32) undergo alterations in human T cell activation.
    Schraven B; Schirren A; Kirchgessner H; Siebert B; Meuer SC
    Eur J Immunol; 1992 Jul; 22(7):1857-63. PubMed ID: 1352500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5.
    Beyers AD; Spruyt LL; Williams AF
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2945-9. PubMed ID: 1372996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical association of the cytoplasmic domain of CD2 with the tyrosine kinases p56lck and p59fyn.
    Carmo AM; Mason DW; Beyers AD
    Eur J Immunol; 1993 Sep; 23(9):2196-201. PubMed ID: 8103744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both T cell receptor (TcR)-CD3 complex and CD2 increase the tyrosine kinase activity of p56lck. CD2 can mediate TcR-CD3-independent and CD45-dependent activation of p56lck.
    Danielian S; Alcover A; Polissard L; Stefanescu M; Acuto O; Fischer S; Fagard R
    Eur J Immunol; 1992 Nov; 22(11):2915-21. PubMed ID: 1358625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a signaling complex involving CD2, zeta chain and p59fyn in T lymphocytes.
    Gassmann M; Amrein KE; Flint NA; Schraven B; Burn P
    Eur J Immunol; 1994 Jan; 24(1):139-44. PubMed ID: 7912674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of CD2 association with T cell receptor signaling molecules in "CD2 unresponsive" human T lymphocytes.
    Schraven B; Wild M; Kirchgessner H; Siebert B; Wallich R; Henning S; Samstag Y; Meuer SC
    Eur J Immunol; 1993 Jan; 23(1):119-23. PubMed ID: 8093441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A serine phosphatase is involved in CD2-mediated activation of human T lymphocytes and natural killer cells.
    Samstag Y; Bader A; Meuer SC
    J Immunol; 1991 Aug; 147(3):788-94. PubMed ID: 1677669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal transduction of interleukin 2 in human natural killer cells: involvement of the p56lck tyrosine kinase.
    Vitte-Mony I; Delespine-Carmagnat M; Bertoglio JH
    Mol Immunol; 1994 Jun; 31(8):623-32. PubMed ID: 7910947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLP-76 binding to p56lck: a role for SLP-76 in CD4-induced desensitization of the TCR/CD3 signaling complex.
    Sanzenbacher R; Kabelitz D; Janssen O
    J Immunol; 1999 Sep; 163(6):3143-52. PubMed ID: 10477581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Src-like protein tyrosine kinases with the CD2 cell surface molecule in rat T lymphocytes and natural killer cells.
    Bell GM; Bolen JB; Imboden JB
    Mol Cell Biol; 1992 Dec; 12(12):5548-54. PubMed ID: 1280324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular alterations of the Fyn-complex occur as late events of human T cell activation.
    Marie-Cardine A; Kirchgessner H; Schraven B
    Eur J Immunol; 1999 Apr; 29(4):1175-87. PubMed ID: 10229084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine kinase p59fyn is associated with the T cell receptor-CD3 complex in functional human lymphocytes.
    Gassmann M; Guttinger M; Amrein KE; Burn P
    Eur J Immunol; 1992 Jan; 22(1):283-6. PubMed ID: 1530920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
    Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
    Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine phosphorylation and association with phospholipase C gamma-1 of the GAP-associated 62-kD protein after CD2 stimulation of Jurkat T cell.
    Hubert P; Debré P; Boumsell L; Bismuth G
    J Exp Med; 1993 Nov; 178(5):1587-96. PubMed ID: 7693851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning of SKAP55, a novel protein that associates with the protein tyrosine kinase p59fyn in human T-lymphocytes.
    Marie-Cardine A; Bruyns E; Eckerskorn C; Kirchgessner H; Meuer SC; Schraven B
    J Biol Chem; 1997 Jun; 272(26):16077-80. PubMed ID: 9195899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional complex is formed in human T lymphocytes between the protein tyrosine phosphatase CD45, the protein tyrosine kinase p56lck and pp32, a possible common substrate.
    Schraven B; Kirchgessner H; Gaber B; Samstag Y; Meuer S
    Eur J Immunol; 1991 Oct; 21(10):2469-77. PubMed ID: 1655467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.
    Wang Q; Stanley J; Kudoh S; Myles J; Kolenko V; Yi T; Tubbs R; Bukowski R; Finke J
    J Immunol; 1995 Aug; 155(3):1382-92. PubMed ID: 7636203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of distinct populations of PI-3 kinase activity following T-cell activation.
    Thompson PA; Gutkind JS; Robbins KC; Ledbetter JA; Bolen JB
    Oncogene; 1992 Apr; 7(4):719-25. PubMed ID: 1373484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.